T. Rowe Price Associates
TNXP icon

T. Rowe Price Associates’s Tonix Pharmaceuticals TNXP Stock Holding History

T. Rowe Price Associates’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– -$10K – 3005
2022
Q1 		– Hold
0
– -$10K – 2956
2021
Q4 		– Hold
0
– -$17K – 2967
2021
Q3 		– Hold
0
– -$29K – 2928
2021
Q2 		– Hold
0
– – – 2903